Neval Ozkaya to Histiocytic Disorders, Malignant
This is a "connection" page, showing publications Neval Ozkaya has written about Histiocytic Disorders, Malignant.
Connection Strength
0.758
-
Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms. Hematol Oncol Clin North Am. 2017 08; 31(4):705-719.
Score: 0.590
-
Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019 03; 567(7749):521-524.
Score: 0.167